A prospective multi-institutional phase II study of everolimus (Rad001), an mtor inhibitor, in pediatric patients with recurrent or progressive low-grade glioma. A poetic consortium trial Meeting Abstract
| Authors: | Kieran, M.; Yao, X.; Macy, M.; Geyer, R.; Cohen, K.; MacDonald, T.; Allen, J.; Boklan, J.; Smith, A.; Nazemi, K.; Gore, L.; Trippett, T.; DiRenzo, J.; Narendran, A.; Perentesis, J.; Prabhu, S.; Pinches, N.; Robison, N.; Manley, P.; Chi, S. |
| Abstract Title: | A prospective multi-institutional phase II study of everolimus (Rad001), an mtor inhibitor, in pediatric patients with recurrent or progressive low-grade glioma. A poetic consortium trial |
| Meeting Title: | 45th Annual Conference of the International Society of Paediatric Oncology (SIOP) |
| Journal Title: | Pediatric Blood and Cancer |
| Volume: | 60 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2013 Sept 25-28 |
| Meeting Location: | Hong Kong, China |
| ISSN: | 1545-5009 |
| Publisher: | Wiley Periodicals, Inc |
| Date Published: | 2013-09-01 |
| Start Page: | 19 |
| End Page: | 20 |
| Language: | English |
| ACCESSION: | WOS:000324735500069 |
| PROVIDER: | wos |
| PUBMED: | 24058053 |
| DOI: | 10.1002/pbc.24719 |
| Notes: | Meeting Abstract: O-0068 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
